Neonatal Resuscitation With Intact Cord (NRIC)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
San Diego, California, United States, 92123
- Sharp Mary Birch Hospital for Women and Newborns
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Gestational Age: Women admitted 23+0 to 31+6 weeks (Reason: Highest risk for IVH)
Exclusion Criteria:
- Gestational Age: Parents decline consent (Reason: Can only perform intervention at time of delivery)
- Congenital anomalies of newborn (Reason: Exclude the effect of abnormal hematological function)
- Placental abruption (Reason: Exclude pregnancies at risk for hemorrhage at the time of delivery)
- Twin to twin transfusion (Reason: Exclude possible loss of blood from other twin during delayed cord clamping)
- Placenta Accreta
- Prolonged premature rupture of membranes (> 2 weeks) prior to 23 weeks gestation
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Ventilation during DCC (V-DCC)
Measuring the volume of placental transfusion with ventilation (CPAP 5 cm H2O between inflations) in infants born by C/S or VG using, as an initial surrogate marker, Hematocrits at 12 hours of life (HOL)
|
Ventilation with CPAP 5 cm H2O between inflations and Delayed clamping of the umbilical cord for 60 seconds
|
|
Active Comparator: DCC plus dry and stimulate
Measuring the volume of placental transfusions with delayed cord clamping alone (DCC) in infants born by C/S or VD using, as an initial surrogate marker, Hematocrits at 12 hours of life (HOL)
|
Delayed clamping of the umbilical cord for 60 seconds
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Peak Hematocrit
Time Frame: within 24 hours
|
within 24 hours
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Maximum inspired oxygen (FiO2) (percentage)
Time Frame: over the first 5 minutes of life
|
over the first 5 minutes of life
|
|
|
Positive Pressure Ventilation given
Time Frame: 1 minute
|
1 minute
|
|
|
DR interventions after delayed cord clamping complete
Time Frame: 10 minutes of life
|
PPV, CPAP, intubation, chest compressions, volume, medications (yes/no)
|
10 minutes of life
|
|
Maximum Peak Inspiratory Pressure (cm H2O)
Time Frame: over the first 5 minutes of life
|
over the first 5 minutes of life
|
|
|
Time to reach heart rate >100 beats per minute (seconds)
Time Frame: over the first 5 minutes of life
|
over the first 5 minutes of life
|
|
|
Time oxygen saturation within and outside of target range (seconds)
Time Frame: over the first 5 minutes of life
|
over the first 5 minutes of life
|
|
|
Time of the resuscitation (minutes)
Time Frame: up to 30 minutes of life
|
up to 30 minutes of life
|
|
|
Time to demonstrate cycling of end tidal CO2 (seconds)
Time Frame: First minute of life
|
Evaluated by analysis of video recording
|
First minute of life
|
|
Maximum End Tidal CO2 (mm Hg)
Time Frame: up to 30 minutes of life
|
up to 30 minutes of life
|
|
|
Intubation (yes/no) in DR/NICU and age (hours)
Time Frame: up to 7 days of life
|
up to 7 days of life
|
|
|
Surfactant (yes/no) in DR/NICU and age (hours)
Time Frame: up to 7 days of life
|
up to 7 days of life
|
|
|
SVC Flow (ml/kg/min)
Time Frame: target time 6 hours of life
|
plus/minus 6 hours
|
target time 6 hours of life
|
|
Right ventricular output (ml/kg/min)
Time Frame: 6 hours of life
|
plus/minus 6 hours
|
6 hours of life
|
|
Cardiac Output by Electrical Cardiometry (ml/kg/min)
Time Frame: over the first 24 hours of life
|
over the first 24 hours of life
|
|
|
Cerebral StO2 by Near-Infrared Spectroscopy
Time Frame: over the first 24 hours of life
|
over the first 24 hours of life
|
|
|
Fractional Oxygen Extraction by Near-Infrared Spectroscopy
Time Frame: 24 hours of life
|
24 hours of life
|
|
|
Color Doppler diameter of ductus arteriosus shunt (mm)
Time Frame: 6 hours of life
|
plus/minus 6 hours
|
6 hours of life
|
|
Pulsed or continuous wave Doppler assessment of ductus arteriosus shunt direction (%time right to left) and velocity (m/s)
Time Frame: 6 hours of life
|
plus/minus 6 hours
|
6 hours of life
|
|
Color Doppler diameter of inter-atrial shunt (mm)
Time Frame: 6 hours of life
|
plus/minus 6 hours
|
6 hours of life
|
|
Pulsed and continuous wave Doppler assessment of inter-atrial shunt direction (% time right to left) and velocity (m/s)
Time Frame: 6 hours of life
|
plus/minus 6 hours
|
6 hours of life
|
|
Peak velocity of the tricuspid regurgitation jet (m/sec) (to calculate arterial pressure)
Time Frame: 6 hours of life
|
plus/minus 6 hours
|
6 hours of life
|
|
Record Blood pressure (SBP/DBP, MAP) and whether hypotensive (defined as < GA on DOL 1) yes/no
Time Frame: over the first 6 hours of life
|
over the first 6 hours of life
|
|
|
Arterial and venous cord pH
Time Frame: at birth (first minute of life)
|
at birth (first minute of life)
|
|
|
Peak total serum bilirubin (mg/dL)
Time Frame: participants will be followed for the duration of hospital stay, an expected average of 48 weeks
|
participants will be followed for the duration of hospital stay, an expected average of 48 weeks
|
|
|
Duration of phototherapy days
Time Frame: participants will be followed for the duration of hospital stay, an expected average of 48 weeks
|
participants will be followed for the duration of hospital stay, an expected average of 48 weeks
|
|
|
Serum hematocrit
Time Frame: at birth, 12 hours, and 30 days of life
|
at birth, 12 hours, and 30 days of life
|
|
|
Admission temperatures (degree Centigrade)
Time Frame: within 1 hour of life
|
within 1 hour of life
|
|
|
Urine output (ml/kg/day)
Time Frame: over the first 72 hours
|
over the first 72 hours
|
|
|
Mean Arterial Blood pressure (mm Hg)
Time Frame: over the first 24 hours
|
over the first 24 hours
|
|
|
Use of cardiac inotropes (dopamine, dobutamine, epinephrine) (yes/no) hypotension
Time Frame: over the first 72 hours
|
over the first 72 hours
|
|
|
Use of postnatal steroids (yes/no)
Time Frame: 4 months or until hospital discharge
|
4 months or until hospital discharge
|
|
|
Presence of intraventricular hemorrhage (yes/no)
Time Frame: participants will be followed for the duration of hospital stay, an expected average of 48 weeks
|
participants will be followed for the duration of hospital stay, an expected average of 48 weeks
|
|
|
Presence of severe intraventricular hemorrhage (Grade 3 or 4) (yes/no)
Time Frame: 4 months or until hospital discharge
|
4 months or until hospital discharge
|
|
|
Presence of PVL (yes/no)
Time Frame: participants will be followed for the duration of hospital stay, an expected average of 48 weeks
|
participants will be followed for the duration of hospital stay, an expected average of 48 weeks
|
|
|
Mortality (yes/no)
Time Frame: participants will be followed for the duration of hospital stay, an expected average of 48 weeks
|
participants will be followed for the duration of hospital stay, an expected average of 48 weeks
|
|
|
Placental Weight
Time Frame: weighed within 24 hours of delivery of the infant
|
weighed within 24 hours of delivery of the infant
|
|
|
Maternal Hemoglobin
Time Frame: in the first 48 hours post delivery of the infant
|
in the first 48 hours post delivery of the infant
|
|
|
Mean Airway Pressure (MAP)
Time Frame: First 5 minutes of life
|
First 5 minutes of life
|
|
|
Duration of CPAP or PPV
Time Frame: First one minute of life
|
Evaluated by analysis of video recording
|
First one minute of life
|
|
Length of umbilical cord allows use of LifeStart bed
Time Frame: First one minute of life
|
Evaluated by analysis of video recording
|
First one minute of life
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- NRIC
- 5R21HD080594 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.